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ABSTRACT 
This study determined the prevalence of Group B Streptococcus (GBS) in late pregnancy and the antimicrobial susceptibility of 
isolated GBS as well as the impact of GBS infections on pregnancy related clinical outcome with a view of providing an 
epidemiological baseline data for policy formulation in the teaching hospital. It is an observational and cross-sectional hospital 
based study. One hundred and fifty pregnant women from 35-40 weeks of gestation were purposively selected and included in 
the study from May to December 2010. Vaginal swab samples were aseptically collected from the subjects after informed 
consent. The samples were assayed for presence of GBS. The susceptibility pattern of the isolated GBS to different antibiotics 
were assessed using disc diffusion and agar dilution techniques based on the Clinical and Laboratory Standards institute(CLSI) 
standards. The result showed prevalence of 11.3% GBS vaginal colonization which increased with age. There was no significant 
association between GBS colonization status and age (p >0.05)), gestational age (p >0.05)), gravidity (p >0.05) and obstetric risk 
factors (p >0.05)). There was no incidence of GBS infection observed. Although, all (17) the GBS isolates were 100% resistance to 
penicillin, ampicillin, cefoxitin and clindamycin. Resistance to cefotaxime (11.8%), erythromycin (64.7%) and vancomycin 70.6% 
were observed. Group B Streptococcus colonization in vagina in late pregnancy has been established in the antenatal clinic of 
the teaching hospital with the attendant risk to the fetus in the population of those affected. There were high and multiple 
resistance patterns of the GBS isolates to different antibiotics in this study. This calls for a review of the present hospital policy 
to include the routine screening of GBS during antenatal visits and surveillance. 
Keywords: GBS, Carriage, Pregnancy and antibiotics resistance. 
INTRODUCTION: 
Maternal infections of Group B Streptococcus (GBS) 
constitute one of the leading pathogens associated 
with both early and late-onset neonatal sepsis (1). The 
bacteria are normally found in the vagina and/or 
lower intestine of 15% to 40% of all healthy.adult 
women (2).  Early onset neonatal sepsis is normally 
related to vaginal carriage in the motherand 
subsequent colonization during birth in 
approximately 70-75% of infants (3). Intrapartum 
prophylaxis has been established to lead to a 70% 
decline in the incidence of GBS disease, however, 
early-onset GBS disease (in infants <7 days old) 
remains a leading cause of illness and death among 
newborns (3, 4). 
 Most data on GBS epidemiology are from Europe 
and North America and a few cases of GBS infections 
(5-7) and carriage as a public health problem have 
been reported from Nigeria (5, 8, 9, 10, 11) and other 
African countries (12, 13, 14). 
 
This study was designed to determine the prevalence 
of GBS in pregnancy and the incidence of GBS 
infections in intrapartum in a tertiary hospital in 
Nigeria. It also determined the antimicrobial 
susceptibility of isolated GBS and assessed the impact 
of GBS infections on the pregnancy related clinical 
outcome with a view of providing an epidemiological 
baseline data for policy formulation in the teaching 
hospital.  
MATERIALS AND METHODS  
Study Area: The study was carried out at the 
Antenatal Clinic of Obafemi Awolowo University 
Teaching Hospital Complex (OAUTHC) and the 
Department of Medical Microbiology and 
Parasitology, Obafemi Awolowo University (OAU), 
Ile-Ife Osun, Nigeria from May to December 2010. It 
was a cross-sectional observational study involving 
pregnant women between 35 and 40 weeks who 
attended the antenatal clinic. Pregnant women who 
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had had antibiotic treatment within the last two 
weeks prior to recruitment were excluded from the 
study. The Ethical Committee of the hospital 
approved the study. 
Study Population  
One hundred and fifty pregnant women were 
sampled following the ethical approval of the study. 
The patients’ consents were sought and gained by 
explaining to them the objectives of the study and the 
benefits there in. Profomas questionnaires were filled 
for the volunteers to acquire demographic and other 
relevant obstetric history.  
Specimen Collection  
Two swab samples were taken per participant and 
using a speculum from the vaginal introitus under 
aseptic condition with a commercially available 
collection and transport system for aerobes and 
anaerobes (Charcoal Swabs Amies Plastic Applicator 
with Rayon Tipped Black Cap, Stone, Staffs, UK). All 
swab specimens were transported to the Medical 
Microbiology Laboratory of OAU. 
Specimen Culture Isolation and Identification, 
Microscopy and Antigen Detection 
The swab samples were inoculated into selective 
enrichment broth medium (Todd-Hewitt broth 
supplemented with 10µ/ml colistin and 15µ/ml 
nalidixic acid, Oxoid England) and were incubated 
aerobically at 37OC for 24 hours. After 24 hours 
incubation, broth cultures were observed for growth 
(Turbidity) and then sub cultured onto 5% Sheep 
Blood Agar (Oxoid England) and incubated overnight 
as above. Suspected GBS isolates were identified 
appropriately as earlier described (9). GBS antigen 
was confirmed definitively by serological grouping 
using Streptococcal group B reagent kit (Oxoid 
England) testing of selective broth (15).  
The results were analyzed using the SPSS software 
(version 11.0) and evaluated statistically by Chi 
square, Pearson Yate’s correction test. Level of 
significance was taken to be P - values <0.05. The 
sensitivity, specificity, positive and negative 
predictive values and efficiency of the antigen 
detection test were evaluated against the culture 
isolation. A pregnant woman was deemed to have 
been positive for GBS colonization when either or 
both culture or antigen detection is positive. 
Antibiotic Susceptibility Testing 
A small number of colonies obtained from each 24 
hours old 5% Sheep blood agar plate culture was 
incubated in Todd-Hewitt broth for 2 hours at 37OC to 
obtain a McFarland level of turbidity of 105 and 
logarithmic-growth phase culture. These were tested 
against different antibiotic discs which included 
penicillin, ampicillin, cefotaxime, clindamycin and  
erythromycin and the Minimum inhibitory 
concentrations were determined based on 
recommended standards (16, 17) and Streptococcus 
pneumoniae ATCC 6305 was used as control organism 
and free drug plate was included as negative control.  
RESULTS 
The study participants reflected the composition of 
the low risk antenatal group at our hospital in their 
age, parity, gravidity and gestational age. One 
hundred and fifty (150) pregnant women participated 
in the study over a period of six months (May to 
December 2010). Their age range was 18-42 years with 
a mean of 30.25 (±4.65) and the age group in years 
was categorized as younger (18-29) and older (≥30) 
pregnant women, which were 64 (42.7%) and 86 
(57.3%) respectively. Table 1 shows parity and 
gestational age among other parameters as indicated.  
In this study, GBS colonization was confirmed by 
antigen detection from enrichment broth culture and 
direct culture isolation of the vaginal swab samples 
(Table 2). Seventeen (17) out of the 20 pregnant 
women that were positive for antigen detection by 
latex agglutination test after 18 hours incubation in 
enrichment broth were also culture positive. In the 
remaining 3 antigen positive women, no GBS could 
be isolated in spite of prolonged incubation 
(>72hours). 
Among the subjects that were colonized with GBS, 
GBS colonization was higher among older women 
with age ≥30 years (12.79%) against 9.38% in younger 
(18-29) women (Table 3). The difference was not 
statistically significant (X2= 0.426; P= 0.514). The age 
distribution of the GBS colonized and non GBS 
colonized population is shown in Figure 1. The GBS 
colonization increases as the age increases and a 
higher colonization was observed in the age range 34-
37 years. The age range of GBS positive women was 
26-36 years with mean of 30.31(±4.346) while GBS 
negative women had age ranging from 18-42 years 
with an average age of 30.17 (±4.741).   
Out of the 17 GBS positive pregnant women, 10 
pregnant women had their gestational age to be ≤37 
weeks but ≥35 weeks while 7 women had their 
gestational age >37 weeks but ≤40 weeks, the 
difference was not statistically significant (X2 = 1.297; 
P = 0.225)(Table 4). The prevalence of GBS 
colonization was observed to be higher at 35 weeks 
gestational age. Among the GBS positive cases, the 
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prevalence of GBS colonization was higher among the 
mtltigravida (64.71%) than the primigravida (35.29%) 
(Table 5). GBS vaginal colonization was not 
statistically associated with gravidity (X2 = 0.375; P = 
0.54).  
 
TABLE 1: CHARACTERISTICS OF THE STUDY PARTICIPANTS 
Characteristics                                                        Frequency (%) 
Age range                                                                        18-42 
Age mean (±sd)                                                               30.25(±4.65) 
Age group in years 
Younger (18-29)                                                         64(42.7) 
Older (≥30)                                                                  86(57.3) 
Parity range                                                                      0-6 
Mean (±sd)                                                                       1.07(±1.221) 
Gravidity 
Primigravida                                                             42(28) 
Multigravida                                                            108(72) 
Gestational age in weeks 
Range                                                                  35-40 
Mean (±sd)                                                                36.81(±1.526) 
 
The statistical analysis of GBS carriage in relation to 
obstetric characteristics is shown in Table 6. Out of 
the one hundred and fifty studied population, only 
forty-two (38%) women came to deliver in the 
hospital eventually. Four (4) out of the forty-two 
(9.52%) were GBS positive women while thirty-eight 
(90.48%) were negative cases. Among the 4 GBS 
positive women, 2 women had gestational age at 
delivery to be <40 weeks whereas, the other 2 
delivered at >40 weeks. The duration of the rupture of 
membrane (ROM) of the 4 positive pregnant women 
was less than 10 hours and only one had spontaneous 
vaginal delivery, the other three delivered through 
emergency cesarean section due to failure to progress 
to secondary labour. Twenty seven (27) (96.43%) out 
of the GBS negative subjects delivered through vagina 
while the remaining 11 (78.57%) subjects had cesarean 
type of delivery. However, GBS colonization was not 
statistically associated with gestational age at 
delivery, duration of rupture of membrane and mode 
of delivery (P = 1) (Table 6).  
 
TABLE 2:  ANTIGEN DETECTION IN CULTURE POSITIVE AND 
CULTURE NEGATIVE CASES 
_________________________________________________________ 
Test Result Culture Positive        Culture Negative   Total 
_________________________________________________________ 
 
Ag Positive          17              3             20 
 
(True Positive) (False Positive) 
 
Ag Negative          0           130                          130 
(False Negative) (True Negative) 
_________________________________________________________ 
Total          17             133                          150 
_________________________________________________________ 
Sensitivity = 100%, Specificity = 95.6%, Positive predictive value = 85%, Negative predictive value = 100% 
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TABLE 3:  PREVALENCE OF GBS VAGINAL COLONIZATION IN RELATION TO AGE 
___________________________________________________________ 
Age (Years) GBS-positive GBS-negative  Total 
___________________________________________________________ 
 
Younger (18-29)     6(9.38)  58(90.62)           64(100) 
 
Older (≥30)    11(12.79) 75(87.21)           86(100) 
___________________________________________________________ 
X2=0.426; P= 0.514 
 
Out of the 42 subjects that delivered in the hospital, 2 
subjects had intrapartum fever; one was GBS positive 
while the second was GBS negative. Four subjects had 
vaginal related infection (Vaginitis) out of which one 
was GBS positive. None of the 4 GBS cases that 
delivered in the hospital had chorioamnionitis,  on the 
other hand, only one subject out of the GBS negative 
cases had the infection. One GBS positive subject had 
fetal distress for an unrelated reason whereas five of 
the GBS negative also had fetal distress. One subject 
each from GBS positive and GBS negative gave birth 
to a neonate with low birth weight. Babies born to 3 
GBS positive subjects had normal .Activity, Pulse, 
Grimace, Appearance and Respiration (APGAR) 
score. While the baby born to the fourth GBS positive 
subject had a critically low APGAR score. On the 
other hand, 35 GBS negative subjects had babies with 
normal APGAR score while the remaining 3 subjects 
delivered babies with low APGAR. For the total 
population that delivered in the hospital, none of the 
following factors that might contribute to colonization 
were found to be significantly associated with GBS 
colonization status (P>0.05) (Table 7).    
Antibiotic resistant pattern of GBS isolates by Disc 
diffusion and agar dilution techniques 
 
Antimicrobial susceptibility pattern of the 17 GBS 
isolates is shown in Figure 2. All the GBS isolates 
showed uniform resistance to penicillin, ampicillin, 
clindamycin and cefoxitin. However, 82.4% of the 
isolates were sensitive to cefotaxime while 17.6% 
were resistant. For erythromycin, 35.3% of the GBS 
isolates displayed both intermediate and total 
resistance whereas, 29.4% of the isolates were 
sensitive to the antibiotic. 70.6% were sensitive to 
vancomycin. Two (11.76%) strains exhibited a 
multiple antibiotic resistance pattern.   
Minimum inhibitory concentrations (MICs) were 
determined by testing all the 17 GBS isolates against 
penicillin, ampicillin, cefotaxime, erythromycin and 
clindamycin by agar dilution method (Figure 3). All 
the isolates tested had uniform resistance (100%) to 
penicillin, ampicillin and clindamycin with MIC 
≥1milligram per litre (mg/l). Of the 17 GBS isolates 
tested for cefotaxime susceptibility, 88.2% (15) were 
susceptible with MICs ≤ 0.5mg/l and 11.8 % (2) were 
resistant with MICs = 8mg/l. For erythromycin 
susceptibility, 35.3% (6) were susceptible with MICs ≤ 
0.25mg/l and 64.7% (11) GBS isolates had MICs ≥ 
1mg/l which were regarded as resistant.    
TABLE 4: PREVALENCE OF GBS COLONIZATION IN RELATION TO GESTATIONAL AGE 
______________________________________________________________ 
Gestational age    GBS-positive       GBS-negative            Total 
______________________________________________________________ 
 
≥35≤37   10(9.43)    96(90.57)  106(100) 
>37≤40  7(15.91)    37(84.09)    44(100) 
______________________________________________________________ 
X2= 1.297; P=0.225 
             
TABLE 5: PREVALENCE OF GBS COLONIZATION IN RELATION TO GRAVIDITY 
____________________________________________________ 
                                                              GBS colonization      Gravidae                                   Total 
                                                                 Primi- (%)         Multi- (%) 
____________________________________________________ 
 
Yes          6(35.29)  11(64.71)          17(100) 
 
 No      38(28.15)  97(71.85)        135(100) 
_____________________________________________________ 

























AntibioticsNo. of S. isolates/% No. of I R. isolates/% No. of R. isolates/%
 TABLE 6: GBS CARRIAGE RATE AND OBSTETRIC CHARACTERISTICS 











    
Gestational age at delivery     
<40 2(9.09) 20(90.91) 22(100) 1 
>40 
 
2(10.00) 18(90.00) 20(100)  
 
Membrane rupture duration 
    
<10hours 4(9.76) 4(9.76) 41(100) 1 
10-18hours 
 
0(0) 1(100) 1(100)  
 
Type of delivery 
    
Vaginal 1(3.57) 27(96.43) 28(100) 1 
Cesarean 
 


























            









Fig 2: Antibiotic resistant profile of GBS isolates by agar diffusion technique 
               KEYS: S = Susceptible, IR = Intermediate Resistant, R = Resistant      
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     Total 
  Number (%)         P-value 
    
Fever     
   Yes 1(50.00) 1(50.00) 2(100)                0.184 
   No 3(7.50) 37(92.50) 40(100)  
 
Vaginitis 
    
    Yes 1(25.00) 3(75.00) 4(100)                 0.341 
     No 3(7.89) 35(92.11) 38(100)  
 
Chorioamnionitis 
    
      Yes 0(0) 1(100) 1(100)                  1 
      No 4(9.76) 37(90.24) 41(100)  
 
Fetal distress 
    
       Yes 1(16.67) 5(83.33) 6(100)                 0.474 
       No 3(8.33) 33(91.67) 36(100)  
 
Low birth weight 
    
         Yes 1(50.00) 1(50.00) 2(100)                 0.184 
         No 3(7.50) 37(92.50) 40(100)  
 
Normal APGAR score 
    
          Yes 3(7.89) 35(92.11) 38(100)                   1 






























percentage of susceptible GBS Isolates percentage of resistant GBS Isolates
 
Fig 3: Antibiotic resistance profile of GBS isolates by agar dilution technique 
DISCUSSION 
This present study has shown the prevalence of GBS 
(Streptococcus agalactiae) colonization in Ile-Ife to be 
11.3%. The rapid antigen detection had a sensitivity of 
100 percent and a specificity of 95.6 percent in our 
center which is comparable to 100% sensitivity and 
98.37% specificity reported by several other authors 
(15, 18). The possibility of a higher sensitivity for latex 
particle agglutination test than the recommended 
culture isolation cannot be ruled out since 
agglutination test is independent of the viability of 
the organism. In this study, there were 3 likely false 
positive and no false negative cases showing that 
antigen detection had a sensitivity of 100% and a 
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specificity of 95.6% with positive predictive value of 
85% and negative predictive value of 100%.  
In this study, we recorded a higher prevalence of 
11.3% GBS vaginal colonization than that reported in 
Jos (6.6%) (9) and Calabar(9%) (19) but lower than 
that reported in Ibadan (17.6%) (5) and Zaria (14%) 
(8). The prevalence rate recorded is comparable to 
11% prevalence obtained in Abeokuta (20) and the 
recent study carried out in Ibadan (10%) (21). 
Therefore, our study further confirms the presence of 
GBS colonization of the vagina in late pregnancy in 
Ile-Ife and corroborated reports from other 
geopolitical zones of the country establishing carriage 
status in pregnancy and the consequent risk to 
maternal and neonatal life. However, there is an 
urgent need to establish the disease burden arising 
from this colonization as all studies reported so far 
failed to address this. 
However, in studies carried out in other African 
countries, higher prevalence rates were obtained, 
such as: Malawi (16.5%) (12), Gambia (22.0%) (13), 
Zimbabwe (20-32%), (14) and) Ivory Coast (19.0%) 
(23).   Other countries where a similar rate was 
reported include; Korea (9.5%) (24), USA (12.2%) (25), 
Iran (9.1%) (26) and Hong Kong (10.4%) (27).  Single 
vaginal culture and lack of rectal culture can partly 
explain the low prevalence in our study, although; 
this may not be a limitation of  this study as a higher 
proportion of GBS have been documented to be  
isolated from the vagina (12.3%) as compared to the 
rectum (5%) in Tanzania (28). Higher prevalence rates 
have been reported in studies that involved 
rectovaginal sample collections and also women with 
ruptured membranes (26). The reason for the varying 
results may be attributed to the fact that GBS 
maternal colonization varies from place to place. 
Other factors that may have contributed to this 
variation include socioeconomic factors, ethnic and 
genetic factors, variation in clinical practices of 
samples collected and the techniques used for the 
sampling. Differences in environmental factors such 
as hygiene and nutrition may also play a role. 
In this study, GBS colonization increases with age. An 
observation also documented by a study in 
Ibadan(22) where they reported increase in GBS 
positivity as age increases. However, this observation 
was not corroborated by another study reported from 
Malawi (12) which reported a decrease in GBS 
colonization as age increases. GBS vaginal 
colonization rate in this present study does not 
statistically relate with age nor gestational age (P> 
0.05). The culture positivity among mothers ≤37 
weeks in gestational age was far less than that among 
mothers >37 weeks which is in agreement with the 
observation of Raj, et. al. (31) that the vaginal 
colonization of GBS varies during the period of 
gestation and that screening earlier than six weeks 
before delivery may not be a true reflection at 
delivery and may not accurately predict the vaginal 
colonization at delivery. Other investigators have 
documented that cultures obtained between one and 
five weeks before delivery have sensitivity of 87% and 
specificity of 97% or higher (32). 
Although very few GBS isolates were evaluated in 
this study in a limited population of pregnant 
women. We are nonetheless alarmed by the high level 
of resistance observed to penicillin and ampicillin 
antibiotics which are the first choice of drugs for 
intrapartum prophylaxis and the challenges which 
this implies. However, many factors may be 
responsible for this observation in this environment 
such as: the ease of procurement of antibiotics in the 
developing country, the frequent use of antibiotics for 
therapy and prophylaxis, and other socio-economic 
factors as documented by Okeke et al. (33). The 
expanded use of beta-lactam antimicrobials in the 
treatment of several infective clinical syndromes and 
the easy of purchase over the counter might be the 
cause of emergence of GBS resistance strains in this 
environment. A study in Tanzania on GBS in 
pregnant women documented resistance to 
clindamycin, erythromycin and penicillin G was 
found to be 17.6%, 13% and 9.4%, respectively (28). 
The high rate of erythromycin and clindamycin 
resistance in GBS in this study is consistent with 
earlier reported observations (24, 25, and 29) on the 
increasing resistant trend of GBS to this drugs which 
underscores the current CDC recommendations that 
antibiotic susceptibility testing be performed if 
erythromycin or clindamycin therapy is needed to 
prevent neonatal GBS infection. GBS erythromycin 
and clindamycin resistance is as a result of the 
acquisition of an erythromycin ribosomal methylase 
(erm) gene which encodes a methylase enzyme that 
modifies the binding site on ribosomal RNA or via the 
constitutive expression of an erm-encoded methylase 
which results in resistance to erythromycin, 
clindamycin and streptogramin B drugs (cMLSB 
phenotype) (34, 35), we believe that these genes may 
be responsible for the observations in this study. 
However, the high susceptibility of 88.2% to 
cefotaxime, a third generation cephalosporin which 
was observed in this study, may possibly be due to 
the limited exposure of subjects to this antibiotics and 
the relatively expensive nature of the drug which 
makes it un-attractive for purchase over the counter. 
This study demonstrated that detection of GBS 
vaginal colonization by lance field antigen grouping 
following enrichment broth culture is more sensitive 
than direct culture isolation; also it reduces the 
turnaround time to 18-24 hours for availability of 
result, unlike the standard culture method that takes 
about 48-72 hours before result is out.  
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The high percentage and multiple resistance patterns 
of GBS to beta-lactam drugs and to clindamycin and 
erythromycin in this environment need to be further 
verified through an expanded study with many more 
women and at several sites with the same study 
protocol. However, the establishment of carriage 
status in pregnant women for GBS calls for a review 
of the present hospital policy on antenatal care to 
include routine screening and reporting of GBS 
prevalence as well as monitoring the level of 
antibiotic resistance in GBS among pregnant women 
during antenatal visits.  
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